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Abstract
Background: The wintertime co-occurrence of peaks in influenza and invasive pneumococcal disease (IPD) is well
documented, but how and whether wintertime peaks caused by these two pathogens are causally related is still uncertain.
We aimed to investigate the relationship between influenza infection and IPD in Ontario, Canada, using several
complementary methodological tools.
Methods and Findings: We evaluated a total number of 38,501 positive influenza tests in Central Ontario and 6,191
episodes of IPD in the Toronto/Peel area, Ontario, Canada, between 1 January 1995 and 3 October 2009, reported through
population-based surveillance. We assessed the relationship between the seasonal wave forms for influenza and IPD using
fast Fourier transforms in order to examine the relationship between these two pathogens over yearly timescales. We also
used three complementary statistical methods (time-series methods, negative binomial regression, and case-crossover
methods) to evaluate the short-term effect of influenza dynamics on pneumococcal risk. Annual periodicity with wintertime
peaks could be demonstrated for IPD, whereas periodicity for influenza was less regular. As for long-term effects, phase and
amplitude terms of pneumococcal and influenza seasonal sine waves were not correlated and meta-analysis confirmed
significant heterogeneity of influenza, but not pneumococcal phase terms. In contrast, influenza was shown to Granger-
cause pneumococcal disease. A short-term association between IPD and influenza could be demonstrated for 1-week lags in
both case-crossover (odds ratio [95% confidence interval] for one case of IPD per 100 influenza cases =1.10 [1.02–1.18]) and
negative binomial regression analysis (incidence rate ratio [95% confidence interval] for one case of IPD per 100 influenza
cases =1.09 [1.05–1.14]).
Conclusions: Our data support the hypothesis that influenza influences bacterial disease incidence by enhancing short-term
risk of invasion in colonized individuals. The absence of correlation between seasonal waveforms, on the other hand,
suggests that bacterial disease transmission is affected to a lesser extent.
Please see later in the article for the Editors’ Summary.
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The seasonal periodicity of pneumonia and influenza deaths in
temperate countries is regarded as sufficiently commonplace that
the term ‘‘flu season’’ is part of the English language vernacular.
However, the widespread recognition of wintertime seasonality of
severe respiratory disease obscures the fact that remarkably little is
understood about the genesis of such seasonality [1,2]. The
wintertime co-occurrence of peaks in viral and bacterial
respiratory disease, including severe invasive disease caused by
Streptococcus pneumoniae, is well documented, but how and whether
wintertime peaks caused by different pathogens are causally
related is unknown. Existing work in this field has consisted largely
of descriptive analyses that have evaluated week-by-week corre-
lations between respiratory virus activity and invasive bacterial
disease, with or without lags [3–5].
However, seasonal oscillation in disease incidence implies a
complex system that includes such elements as loss of immunity
and seasonally enhanced transmissibility with the latter potentially
attributable to environmental, microbiological, or social forcing
factors. Such a complex system cannot be adequately character-
ized by evaluating cross-sectional correlation in risk, particularly
where causal links are concerned. Indeed, statistically significant
correlation in risk when evaluating disease processes with shared
seasonality is to be expected, and such correlation could be casual,
as seen with many human respiratory pathogens with a peak
incidence in winter, rather than causal.
We aimed to investigate the relationship between influenza
infection and invasive pneumococcal disease (IPD) in Ontario,
Canada, using several complementary methodological tools. We
evaluated the relationship between the seasonal wave forms for
influenza and IPD using fast Fourier transforms in order to
examine the relationship between these epidemic waveforms over
yearly timescales, i.e., to test the hypothesis that influenza
influences IPD by enhancing person-to-person transmission. We
also used three complementary statistical methods (time-series
methods, negative binomial regression, and case-crossover meth-
ods) to evaluate the short-term effect of influenza dynamics on
pneumococcal risk, i.e., to examine whether the risk of IPD is
increased in previously colonized individuals.
Materials and Methods
Ethics Statement
The Toronto Invasive Bacterial Diseases Network (TIBDN)
study was approved by Research Ethics Boards at all participating
institutions. Ethical approval was not required for the remainder of
this work.
Population-Based Surveillance for Invasive Pneumococcal
Infections
The Toronto Invasive Bacterial Diseases Network is a
collaboration of all hospitals, microbiology laboratories, infection
control practitioners, physicians, and public health units serving
the population of metropolitan Toronto and Peel Regions
(population 3.7 million), performing population-based surveillance
for selected serious bacterial and viral infections [6–8]. All 25
hospitals, 19 laboratories, and 85 long-term care facilities serving
residents of the population area participate in this network. All
invasive pneumococcal infections identified in residents of
Toronto/Peel from 1 January 1995 through 3 October 2009
were included in the analysis. Invasive pneumococcal infection was
defined as illness in which S. pneumoniae was isolated from a
normally sterile body site. When S. pneumoniae was isolated from
specimens obtained from residents of the study area (defined by
postal code), informed consent was obtained to collect isolates and
detailed clinical data, including age, sex, and site of infection.
Isolates were then sent to the central laboratory at Mount Sinai
Hospital (Toronto), where they were confirmed as S. pneumoniae by
standard methodology, including colonial morphology on blood
agar, bile solubility, and susceptibility to optochin. Annual audits
are conducted to ensure completeness of reporting.
Surveillance for Influenza Infections
A national network of hospital and provincial laboratories
submit weekly reports of numbers of tests performed (using viral
culture or direct antigen detection) and numbers of positive tests
for influenza A and influenza B to the Public Health Agency of
Canada. For the purpose of this study, the surveillance data of the
province of Ontario from 1 January 1995 through 3 October 2009
were included in the analysis.
Environmental Exposure Data
We obtained time series data on ultraviolet (UV) radiation and
weather from Environment Canada monitoring stations in the
Greater Toronto Area [9,10]. Where daily readings were taken at
multiple locations, the arithmetic means of environmental data
were used as exposure variables.
Statistical Analysis
Evaluation of seasonal waveforms. The seasonality of
disease occurrence was evaluated through calculation of
autocorrelations for weekly case counts [2]. As yearly periodicity
was observed with IPD, we estimated seasonal trends in disease
occurrence of IPD and influenza A and B using Poisson and
negative binomial regression models that incorporated sine and
cosineoscillators,with 52-wk (annual)frequencies (i.e., incorporated
fast Fourier transforms) [2,11]. Using these parameters, the
expression for the expected number of case counts for a given
week, E(Y) is given by: E(Y)= e
a + b1Nsin(2p(week/52))+b2Ncos(2p(week/52)).
Accordingly, the phase-shift of the composite waveform generated
by combining sine and cosine components can be approximated as
tan
21(b1/b2) and can be used to estimate the timing of peak disease
incidence [11]. Similarly, the amplitude (i.e., the maximum disease
incidence) can be approximated as !(b1
2 + b2
2). Standard errors for
phase-shift and amplitude were estimatedas sumsof standard errors
for each model coefficient minus covariance. We evaluated the
correlation between phase and amplitude terms for influenza A and
B (combined), influenza A, and influenza B and pneumococcal sine
waves, by year, by calculating Spearman correlation coefficients.
Heterogeneity of phase and amplitude terms for S. pneumoniae,
influenza A and B (combined), influenza A, and influenza B was
assessed through meta-analysis using Cochran’s Q test, and
quantified using I
2 statistics. Differences in the magnitude of
heterogeneity of amplitude or phase by pathogen was assessed using
Knepp and Entwisle’s method for assessing difference between chi-
squared statistics [12]. As the 2003/2004 and 2008/2009 influenza
seasons were outliers with respect to timing and amplitude, and we
also performed sensitivity analyses in which these years were
excluded.
Negative binomial regression models. As both deviance and
Pearson goodness-of-fit statistics suggested over-dispersion of
pneumococcal case counts, we evaluated the relationship between
IPD rates, influenza, and environmental exposures using a series of
negative binomial regression models [13]. Models incorporated
population data derived from the 2001 and 2006 censes as offsets,
with linear interpolation and extrapolation used to generate
population denominators for noncensus years [14]. Model
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influenza A, or influenza B on IPD risk was performed by including
viral infection incidence and environmental exposures considered a
priori to be likely to influence pneumococcal disease epidemiology.
Candidate exposures were based on prior observations by our
group and previously published research by others [5,15–17].
Environmental exposures included UV index, temperature, and
relative humidity and both virological and environmental exposures
were considered at lags of up to 4 wk prior to pneumococcal case
occurrence, which we considered to be a biologically plausible
window for effects. Models also incorporated seasonal and multi-year
trend terms.
Once models had been fitted, we attempted to enhance model
parsimony through model reduction, removing terms that had no
influence on pneumococcal case counts, in a manner that
minimized Akaike’s information criterion (AIC), with final models
representing those that best balanced parsimony and fit [18]. In
models in which viral exposures were evaluated using either total
influenza counts or influenza A counts, strong and statistically
significant associations were observed between influenza burden,
UV index, and relative humidity; we explored multiplicative
interaction terms using categorical variables representing the
highest quintile ranks of these exposures [19]. As noted above the
2004 and 2009 influenza seasons were outliers with respect to
timing and amplitude, and we also performed sensitivity analyses
in which models were reconstructed excluding these years.
Time series methods. Granger causality Wald testing was
used to determine whether influenza A and B (combined),
influenza A, and influenza B seasons can be used to forecast
peaks in pneumococcal infections [20]. Originally, Granger
methods were used in econometrics to evaluate the directionality
of relationships between closely correlated time series; a causal
exposure to an independent variable should be associated with a
lagged change in the dependent variable, and this relationship
should be absent when the temporal sequence of exposure and
response is reversed. In other words, Granger ‘‘causality’’ can be
used to postulate causality in linear prediction only if one thing
happens before another, and not vice versa. It cannot be used to
prove causation, but does provide important evidence that can
support or refute causality.
Case-crossoveranalysis. We used a case-crossoverapproach
to evaluate short-term associations between influenza A and B
(combined), influenza A, and influenza B infection and IPD
occurrence during influenza seasons in order to provide a means
for evaluating the association between brief exposures and rare
outcomes. The design is characterized by ‘‘self matching,’’ in that
cases serve as their own controls. A ‘‘case’’ thereby is a day on which
a case occurred, whereas a ‘‘control’’ is an adequately selected day
on which a case didnot occur [21,22]. A time-stratified 2:1matched
case-crossover design in which hazard periods were defined as the
reported date of IPD onset from the Toronto Invasive Bacterial
DiseasesNetworkdatabasewasincorporated.BeginningonJanuary
1, 1995, the person-time at risk was divided into 3-wk time strata.
Control periods were chosen by matching the hazard period by day
of the week withinthestratum, and could both precede, both follow,
or straddle the hazard period [23,24]. Random directionality of
Figure 1. Surveillance for influenza A and B and IPD. Weekly numbers of IPD (black bars) and positive tests for influenza A (thin curve) and B
(thick curve). in the areas under surveillance from January 1995 to October 2009.
doi:10.1371/journal.pmed.1001042.g001
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unidirectional or uniform bidirectional control selection [24]. We
evaluated the effects of influenza exposures and environmental
covariates through construction of conditional logistic regression
models with time lags from 0 to 4 wk.
Data were analyzed using Stata version 11.0 (Stata Corporation)
and SAS version 9.1 (SAS Institute). p-Values of ,0.05 were
considered statistically significant.
Results
The period from 1 January 1995 through 3 October 2009 was
available for analysis, including a total number of 38,501 positive
influenza tests in Ontario and 6,191 episodes of pneumococcal
disease in Metropolitan Toronto/Peel Region (Figure 1).
Periodicity of Influenza and Pneumococcal Disease
Annual periodicity (i.e., recurrence at annual intervals) could be
demonstrated for pneumococcal disease by spectral decomposition
and construction of autocorrelations, with a maximum autocor-
relation coefficient (ac) =0.4488 at week 52 (Figures 1 and 2).
Peak incidence could be observed in week 6 (mid-February).
Periodicity of influenza infections was less regular; the maximum
ac could be identified at 59-week lags for influenza A and B
(combined) (ac =0.3514), at 59-week lags for influenza A (ac
=0.2922), and at 48-week lags for influenza B (ac =0.2903).
Negative binomial regression models revealed strong statistical
evidence for annual oscillation for both pneumococcal disease and
combined influenzaA and B infections (p for nonlinearcombination
of sine and cosine oscillators for both pathogens ,0.001). Whereas
meta-analyses revealed substantial heterogeneity of phase (Cochran
Q statistic: x
2=62810.15, df =15, p,0.001; I
2=100.0%) and
amplitude (Cochran Q statistic: x
2=5752.86, df =15, p,0.001;
I
2=99.7%) terms for influenza A and B (combined), there was less
heterogeneity of amplitude (Cochran Q statistic: x
2=40.06, df =
15, p,0.001; I
2=62.6%) terms for S. pneumoniae, and no significant
heterogeneity for phase (Cochran Q statistic: x
2=23.28, df =15,
p=0.08; I
2=35.6%) terms. Differences in heterogeneity x
2 statistics
between pathogens [12] were highly significant for both amplitude
and phase terms (p,0.001). Heterogeneity of phase and amplitude
terms of influenza A and influenza B was in line with influenza A
and B (combined) (unpublished data). Findings were robust when
outlier seasons (2003–2004 and 2008–2009) were excluded in
sensitivity analyses.
Figure 2. Periodicity of influenza and IPD. Periodicity of (A) IPD, (B) influenza A and B (combined), (C) influenza A, and (D) influenza B in the
Toronto-Peel area, Ontario, Canada as illustrated by autocorrelograms, for the time period from January 1995 to October 2009.
doi:10.1371/journal.pmed.1001042.g002
Influenza and Pneumococcal Disease
PLoS Medicine | www.plosmedicine.org 4 June 2011 | Volume 8 | Issue 6 | e1001042Accordingly, no significant association between amplitude and
phase of oscillatory waves of pneumococcal disease and influenza
A and B (combined), influenza A, or influenza B could be detected
using Spearman correlation (Tables 1–3).
Acute Effects during Influenza Season
Negative binomial regression analysis. Results from
negative binomial regression analysis suggest influenza A and B
(combined) activity is associated with IPD (incidence rate ratio =
1.09 case of IPD per 100 influenza cases, p,0.001), after
adjustment for seasonal oscillation, multi-year trends, humidity,
temperature, and UV index. Furthermore, there is an inverse
association between average clear-sky UV index, both during the
prior week, and 3 wk prior, and IPD (Table 4). Increased relative
humidity was also associated with reduced risk of case occurrence.
Models constructed using influenza A counts rather than total
counts were identical in covariates and model performance to
those constructed using total influenza counts (consistent with the
large predominance of influenza A infections identified by the
FluWatch system). We identified no significant interactions
between influenza counts, UV index, and humidity. There was
no significant association between influenza B incidence and IPD
risk in either univariable or multivariable models. Model results
were robust when we excluded influenza seasons that appeared to
be outliers with respect to incidence (2003–2004 and 2008–2009)
(unpublished data).
GrangercausalityWaldtest. Based on the Granger causality
Wald test, there is evidence that influenza A and B (combined)
Granger-cause pneumococcal disease (Chi-square =23.28, df =2,
p,0.001). These results could be reproduced for influenza A
(p,0.001) and influenza B (p=0.017). Conversely, pneumococcal
disease could not be shown to Granger-cause influenza A and B
(combined) infection (Chi-square =4.39, df =2, p=0.11).
Case-crossover results. We were able to identify a
significant association between total influenza (A and B) and
IPD with a 1-wk lag using a case-crossover approach (odds ratio
[95% confidence interval] for one case of IPD per 100 influenza
cases, 1.10 [1.02–1.18]) (Table 5). There was no significant
association between IPD risk and daily changes in clear-sky UV
index, temperature, or relative humidity.
Discussion
Although this observational study cannot prove epidemiological
causality, our analysis of seasonal oscillation in IPD and influenza
A and B incidence in Ontario, Canada, is strongly suggestive of a
causal relationship between influenza and IPD. The fact that we
did not find a relationship between seasonal dynamics of influenza
and IPD suggests that this relationship likely results from effects of
influenza on risk of invasive disease in individuals with
pneumococcal colonization. We found no epidemiological evi-
dence to support the concept that influenza has a strong effect on
IPD risk via changes in pneumococcal transmission dynamics that
would be caused by enhanced susceptibility to pneumococcal
colonization, increased infectiousness of pneumococcus-colonized
individuals, or increased duration of carriage. All such changes
would be expected to perturb the dynamics of pneumococcal
seasonality in such a way that pneumococcal seasonal waves would
‘‘track’’ influenza waves. While we found significant and
temporally directional relationships between influenza burden in
the population and IPD risk, the seasonal ‘‘waves’’ of influenza
and IPD were independent of one another, with substantial
variability in influenza contrasted with the far more regular
seasonal occurrence of IPD. The nonstereotyped nature of
wintertime seasonality of viral respiratory pathogens has been
noted previously [17].
While prior work has evaluated the impact of influenza infection
on pneumococcal risk, much of this work has been performed in
experimental rodent models that may not be generalizable to
human populations [25–27]. A number of epidemiological
analyses have been performed; many have failed to account for
either confounding by other seasonal factors, or ‘‘ecological
fallacy’’ resulting from the use of aggregated exposure and
outcome data [3–5,28]. More methodologically sophisticated
studies have yielded conflicting results on the link between
influenza and IPD [29–31].
Table 2. Spearman correlation coefficients for the association of phase and amplitude terms for influenza A and pneumococcal
sine waves.
Phase or Amplitude Phase Influenza A Amplitude S. pneumoniae Phase S. pneumoniae
Amplitude influenza A 20.19 (0.48) 20.06 (0.83) 20.20 (0.05)
Phase influenza A — 20.11 (0.70) 0.12 (0.65)
Amplitude S. pneumoniae —— 20.49 (0.05)
Data are presented as Spearman correlation coefficient (p-value).
doi:10.1371/journal.pmed.1001042.t002
Table 1. Spearman correlation coefficients for the association of phase and amplitude terms for influenza A and B (combined) and
pneumococcal sine waves.
Phase or Amplitude
Phase
Influenza A and B
Amplitude
S. pneumoniae
Phase
S. pneumoniae
Amplitude influenza A and B 20.30 (0.26) 0.19 (0.49) 20.35 (0.18)
Phase influenza A and B — 20.06 (0.83) 0.09 (0.75)
Amplitude S. pneumoniae —— 20.49 (0.05)
Data are presented as Spearman correlation coefficient (p-value).
doi:10.1371/journal.pmed.1001042.t001
Influenza and Pneumococcal Disease
PLoS Medicine | www.plosmedicine.org 5 June 2011 | Volume 8 | Issue 6 | e1001042The major clinical implications of our study are 2-fold: first, that
dramatic increases in influenza incidence, as might be seen during
a pandemic year, would not in and of themselves imply a marked
surge in risk of IPD, but rather would do so only if there were
overlap between flu and pneumococcal waves. This observation
may help explain the absence of a marked increase in IPD risk in
our jurisdiction during the (atypical) spring wave of the 2009
influenza A-H1N1 pandemic. Although public health agencies
issued calls for stepped-up pneumococcal vaccination because of
the pandemic [32], the fact that the pandemic and pneumococcal
season were out of phase may have made this unnecessary.
Second, the short-term surge in IPD risk accompanying lagged
increases in influenza, if causal, implies that some fraction of IPD
is ‘‘influenza-attributable.’’ As such there may be important
unrecognized population health benefits associated with influenza
vaccination programs that include younger individuals. Tradition-
ally, influenza immunization programs have focused on older
individuals and sometimes the very young, as the risk of adverse
outcomes of flu appear greatest in these age groups. Some
modelers have recommended younger individuals be targeted with
influenza vaccination in order to protect older individuals from
influenza via herd effects, and these projections appear to have
been borne out in at least one recent randomized trial [33,34].
However, IPD causes important morbidity in those in age groups
not included in traditional influenza immunization programs, and
our analysis suggests that prevention of influenza-attributable
pneumococcal disease could also be considered as a benefit of
influenza vaccination targeting older children and younger adults.
If our findings are correct, and influenza increases the risk of
IPD without influencing pneumococcal transmission dynamics,
the question remains: what are the drivers of the remarkably
stereotyped seasonality of IPD? Crude correlations between IPD
risk and mean weekly temperature and mean weekly minutes of
darkness, but not precipitation, have been reported by Dowell
et al. [35]. A previous study by our group of environmental
determinants of IPD risk in Philadelphia [22], identified
diminished ambient UV radiation as a significant predictor of
increased IPD risk, an effect that could either be due to effects of
UV radiation on 1,25-(OH)2-vitamin-D metabolism, or direct
mutagenic effects on vegetative bacteria. The current study,
performed in a different jurisdiction, replicates this finding.
Like any observational study, ours has several limitations. As it is
not possible to randomize exposure to influenza, or to meteoro-
logical exposures, observational studies like this one are necessary
to evaluate the impact of such exposures on invasive bacterial
disease risk in real-world human populations. Limitations of
observational designs like the one we have used here include
difficulties with residual confounding, ecological fallacy due to
aggregation of exposures, and measurement issues. While it is not
possible to control for all residual confounding by unmeasured
confounders in regression models, our use of seasonal smoothers,
multivariable techniques, and case-crossover design should largely
have controlled for confounding of influenza effects by seasonally
varying factors including seasonal behaviors and meteorological
effects. Our use of case-crossover design implicitly matches for all
seasonal effects that would be constant over the 3-wk time block
used for each risk stratum. The case-crossover approach assumes
that the distribution of exposure is constant across referent times,
which should be controlled by careful referent selection. It can be
associated with bias if referent periods are not chosen a priori or if
referents are functions of the observed event times [36]. In order to
circumvent this so-called ‘‘overlap bias,’’ control periods in our
analysis were chosen by matching the hazard period by day of the
week within the 3-wk stratum, and could both precede, both
follow, or straddle the hazard period [24].
Although implied by its name, Granger causality testing does
not prove true causation in the epidemiologic sense. It originally is
an econometric method to infer predictive value of one time series
Table 4. Short-term effects of influenza dynamics on pneumococcal risk using multivariable negative binomial regression analysis.
Negative Binomial Regression Analysis Incidence Rate Ratio 95% Confidence Interval p-Value
Influenza A and B (combined, per 100 infections), 1-wk lag 1.092 1.047–1.138 ,0.001
Influenza A and B (combined, per 100 infections), 3-wk lag 0.932 0.890–0.976 0.003
UVI average, 1-wk lag 0.927 0.893–0.963 ,0.001
UVI average, 3-wk lag 0.946 0.917–0.976 ,0.001
Relative humidity, 1-wk lag (%) 0.995 0.991–1.000 0.03
Mean temperature, 2-wk lag (uC) 0.993 0.984–1.002 0.14
Mean temperature, 4-wk lag (uC) 1.004 0.995–1.012 0.39
Model is also adjusted for year and seasonal oscillation.
UVI, clear-sky UV-index.
doi:10.1371/journal.pmed.1001042.t004
Table 3. Spearman correlation coefficients for the association of phase and amplitude terms for influenza B and pneumococcal
sine waves.
Phase or Amplitude Phase Influenza B Amplitude S. pneumoniae Phase S. pneumoniae
Amplitude influenza B 20.38 (0.15) 0.07 (0.80) 0.06 (0.84)
Phase influenza B — 20.29 (0.28) 0.06 (0.81)
Amplitude S. pneumoniae —— 20.49 (0.05)
Data are presented as Spearman correlation coefficient (p-value).
doi:10.1371/journal.pmed.1001042.t003
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valuable piece to the overall interpretation of our analyses towards
potential causation. With respect to ecological effects, it should be
noted that we effectively treat influenza as an aggregate
‘‘environmental’’ exposure, in that we don’t have influenza status
on the individuals who develop invasive bacterial disease, which
creates the risk of ecological effects, including ecological fallacy, in
our study. There are practical barriers to formulating an
adequately powered study that actually captured data on the
temporal relationship between influenza and invasive bacterial
disease at the level of the individual (e.g., through ongoing
evaluation of individuals in the population for influenza infection,
with subsequent identification of the [rare] individuals who
developed invasive bacterial disease).
Finally, with respect to measurement issues, for influenza A and
B, we had to rely on public health surveillance data that are
incomplete both because of under-reporting, and also because a
majority of individuals with influenza never undergo virological
testing [37]. Other exposures may have been misclassified because
of measurement or population mobility. This misclassification
should not have introduced bias into our study in the absence of
correlation between pneumococcal risk and influenza or meteoro-
logical reporting but may have reduced our statistical efficiency.
Nondifferential misclassification of exposures would mean that the
effects reported here are likely to be lower-bound effects, with true
effects being larger. Furthermore, the strong degree of agreement in
our findings, across multiple methodological approaches, suggests
that they are robust and not artifacts of the analytic approach taken.
In conclusion, our data support the hypothesis that influenza
influences IPD risk by enhancing pneumococcal invasion in
colonized individuals, but has little effect on the transmission
dynamics of pneumococcal infection. We suggest that the
mechanism for such an effect might be influenza-related alterations
at the level of the respiratory epithelium [27]. These effects appear
distinct from those of ambient environmental effects, although the
effect of increased UV radiation in reducing IPD risk that we had
previously reported in a study performed in Philadelphia needs
further study [22]. These findings have important implications for
disease control policy, and suggest that improved efficacy of
influenza vaccines [38], and novel vaccination strategies that more
effectively control influenza by vaccinating younger individuals
[33], could have important effects in reducing IPD as well.
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Background. Although some pathogens (disease-causing
organisms) cause illness all year round, others are
responsible for seasonal peaks of illness. These peaks occur
because of a complex interplay of factors such as the loss of
immunity to the pathogen over time and seasonal changes
in the pathogen’s ability to infect new individuals. Thus, in
temperate countries in the northern hemisphere, illness
caused by influenza viruses (pathogens that infect the nose,
throat, and airways) usually peaks between December and
March, perhaps because weather conditions during these
months favor the survival of influenza virus in the
environment and thus increase its chances of being
transferred among people. Another illness that peaks
during the winter months in temperate regions is
pneumonia, a severe lung infection that is often caused by
Streptococcus pneumoniae. These bacteria can colonize the
back of the throat without causing disease but occasionally
spread into the lungs and other organs where they cause
potentially fatal invasive pneumococcal disease (IPD).
Why Was This Study Done? Although the co-occurrence
of seasonal peaks of influenza and IPD is well documented, it
is unclear whether (or how) these peaks are causally related.
For example, do the peaks of influenza and IPD both occur in
the winter because influenza enhances person-to-person
transmission of S. pneumoniae (hypothesis 1)? Alternatively,
do the diseases co-occur because influenza infection
increases the risk of IPD in individuals who are already
colonized with S. pneumoniae (hypothesis 2)? Healthcare
professionals need to know whether there is a causal
relationship between influenza and IPD so that they can
target vaccination for both diseases to those individuals
most at risk of developing the potentially serious
complications of these diseases. In this study, the
researchers use several mathematical and statistical
methods and data on influenza and IPD collected in
Ontario, Canada to investigate the relationship between
these seasonal illnesses.
What Did the Researchers Do and Find? Between
January 1995 and October 2009, 38,501 positive influenza
tests were recorded in Ontario by the Canadian national
influenza surveillance network. Over the same time period,
the Toronto Invasive Bacterial Diseases Network (a group of
hospitals, laboratories, and doctors that undertakes
population-based surveillance for serious bacterial
infections in the Toronto and Peel Regions of Ontario)
recorded 6,191 IPD episodes. The researchers used a
mathematical method called fast Fourier transforms that
compares the shape of wave forms to look for any
relationship between infections with the two pathogens
over yearly timescales (a test of hypothesis 1) and three
statistical methods to evaluate the short-term effect of
influenza dynamics on IPD risk (tests of hypothesis 2).
Although they found wintertime peaks for infections with
both pathogens, there was no correlation between the
seasonal wave forms for influenza and IPD. That is, there was
no relationship between the seasonal patterns of the two
infections. By contrast, two of the statistical methods used to
test hypothesis 2 revealed a short-term association between
infections with influenza and with IPD. Moreover, the third
statistical method (the Granger causality Wald test, a type of
time-series analysis) provided evidence that data collected at
intervals on influenza can be used to predict peaks in IPD
infections.
What Do These Findings Mean? These findings support
(but do not prove) the hypothesis that influenza influences
IPD incidence by enhancing the short-term risk of bacterial
invasion in individuals already colonized with S. pneumoniae,
possibly by increasing the permeability of the lining of the
airways to bacteria. By contrast, the lack of correlation
between the seasonal wave forms for the two diseases
suggests that person-to-person transfer of S. pneumoniae is
affected by influenza infections to a lesser extent. These
findings have important implications for disease control
policy. First, they suggest that the increased number of
influenza infections in pandemic years may not necessarily
be accompanied by a marked surge in IPD. Second, because
the findings suggest that some cases of IPD may be
influenza-attributable, the extension of influenza
vaccination to school-age children and young adults (a
group of people at particular risk of IPD who are not
normally vaccinated against influenza) could reduce the
incidence of IPD as well as the incidence of influenza.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001042
N A related research article by the same authors evaluating
links between respiratory viruses and invasive meningo-
coccal disease can be found in PLoS One (e0015493)
N The US Centers for Disease Control and Prevention
provides information for patients and health professionals
on all aspects of seasonal influenza and pneumococcal
disease and pneumococcal vaccination
N The UK National Health Service Choices website also
provides information for patients about seasonal influenza
and pneumococcal infection
N MedlinePlus has links to further information about
influenza and pneumococcal infections (in English and
Spanish)
N FluWatch is the Canadian national surveillance system for
influenza
N More information about the Toronto Invasive Bacterial
Network is available
N The International Association for Ecology and Health
provides information on the physical environment and its
influence on health
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